Think it's Ok...but I ain't no doc
The only exception was topiramate, which exhibited higher reporting of vision impairment than semaglutide (rOR 0.30, 95% CI 0.200.45)
Different GLP-1 receptor agonists have varying pharmacokinetic profiles and receptor binding characteristics
One in 10 women aged 35-54 are using the drugs, while usage peaks among 25- to 44-year-olds at 13%, says Tamara Sender Ceron, who heads up fashion retail at the market research company Mintel
"By staying vigilant, seeking early dental advice, and making a few small changes, patients can protect their smiles while achieving their wellness goals." Its yet another reminder that the journey to a healthier you is not just about the number on the scale, its about preserving every part of your well-being, including that radiant, confident smile.
Because both medications act on appetite and glucose metabolism, they are the two most commonly compared options when people research GLP-1 microdosing